Boundless Bio, Inc. Common Stock (BOLD) — Financial Flexibility Index
Boundless Bio, Inc. Common Stock (BOLD) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of $-10.18 Million (operating CF $-10.20 Million minus capex $15.00K) represents 0% of total liabilities ($58.55 Million). Check how resilient are Boundless Bio, Inc. Common Stock's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Boundless Bio, Inc. Common Stock Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Boundless Bio, Inc. Common Stock across 7 annual periods. See how liquid is Boundless Bio, Inc. Common Stock's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Boundless Bio, Inc. Common Stock (2016–2024)
Year-by-year free cash flow to debt coverage for Boundless Bio, Inc. Common Stock. For the full company profile including market capitalisation, see Boundless Bio, Inc. Common Stock (BOLD) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.05x | $-58.30 Million | $-60.84 Million | $55.77 Million | ▼ -481.3% |
| 2023 | -0.18x | $-46.22 Million | $-46.85 Million | $256.98 Million | ▲ +26.0% |
| 2022 | -0.24x | $-38.53 Million | $-39.60 Million | $158.53 Million | ▼ -74.0% |
| 2021 | -0.14x | $-21.21 Million | $-23.25 Million | $151.91 Million | ▲ +95.7% |
| 2018 | -3.23x | $-96.37 Million | $-107.98 Million | $29.80 Million | ▲ +7.3% |
| 2017 | -3.49x | $-76.96 Million | $-84.51 Million | $22.06 Million | ▼ -144.5% |
| 2016 | -1.43x | $-32.37 Million | $-49.02 Million | $22.69 Million | — |